Discover open access scientific publications

Search, annotate, share and cite publications

Publications by S. Niho

MA 17.06 Safety Data From Randomized Phase II Study of CDDP+S-1 vs CDDP+PEM Combined With TRT for Locally Advanced Non-Squamous NSCLC

Journal of Thoracic Oncology

Respiratory Medicine

English

P1.09-33 Validity of Non-Small Cell Lung Cancer Not Otherwise Specified to Use Immunohistochemistry on Treatment Outcome

Journal of Thoracic Oncology

Respiratory Medicine

English

Related publications

P1.01-33 Randomized Phase 2 Study Comparing CBDCA+PTX+BEV and CDDP+PEM+BEV in Treatment-Naïve Advanced Non-Sq NSCLC (CLEAR Study)

Journal of Thoracic Oncology

Respiratory Medicine

English

Balloon Occluded Arterial Infusion of CDDP Combined With Angiotension Ii for Advanced Bladder Carcinoma

Japanese Journal of Urology

English

Multicenter Phase II Trial of Preoperative Chemoradiotherapy With S-1 for Locally Advanced Oral Squamous Cell Carcinoma

Cancer Chemotherapy and Pharmacology

Cancer Research

English

A Comparative Statistical Analysis of CDDP+5-FU (CF) and CDDP+PEP (CP) for Head and Neck Squamous Cell Carcinoma.

Japanese jornal of Head and Neck Cancer

English

Phase I Study of Miriplatin Combined With Transarterial Chemotherapy Using CDDP Powder in Patients With Hepatocellular Carcinoma

BMC Gastroenterology

Gastroenterology

English

Fludarabine Combined With Radiotherapy in Patients With Locally Advanced NSCLC Lung Carcinoma: A Phase I Study

Journal of Cancer Research and Clinical Oncology

Cancer Research

English

P3.01-90 a Phase II Study Evaluating Continuation of EGFR-TKIs Beyond Progressive Disease Followed by the Addition of CDDP+PEM+Bev

Journal of Thoracic Oncology

Respiratory Medicine

English

Phase II Study of S-1 and Docetaxel for Previously Treated Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Cancer Chemotherapy and Pharmacology

Cancer Research

English

Redox Control of Resistance to Cis-Diamminedichloroplatinum (II) (CDDP): Protective Effect of Human Thioredoxin Against CDDP-induced Cytotoxicity.

Journal of Clinical Investigation

English